logo
  

Teva Pharmaceutical Industries Limited Q1 Earnings Summary

Below are the earnings highlights for Teva Pharmaceutical Industries Limited (TEVA):

Earnings: -$955 million in Q1 vs. $77 million in the same period last year.
EPS: -$0.86 in Q1 vs. $0.07 in the same period last year.
Excluding items, Teva Pharmaceutical Industries Limited reported adjusted earnings of $609 million or $0.55 per share for the period.

Analysts projected $0.55 per share
Revenue: $3.66 billion in Q1 vs. $3.98 billion in the same period last year.

-Guidance:
Full year EPS guidance: $2.40 - $2.60
Full year revenue guidance: $15.4 - $16.0 Bln

For comments and feedback contact: editorial@rttnews.com

Follow RTT